Tissue adhesive vs sutures for closing oral biopsy wounds
Official title: Comparison of Tissue Adhesive and Surgical Sutures for Wound Closure After Oral Excisional Biopsies: A Randomized Controlled Clinical Trial
Run by Damascus University · NCT07654166 · Data updated 2026-11-12
This study tests whether a tissue adhesive called PeriAcryl 90 HV can close oral biopsy sites as effectively as traditional sutures in people with oral fibromas.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 28 (estimated) |
| Sponsor | Damascus University Academic / other |
| Locations | 1 site (Damascus, Mazzh) |
| Status | Recruiting |
| Started | August 12, 2025 |
| Main results expected | December 2026 |
| Study ends | December 2027 |
| Registry record updated | June 18, 2026 |
| Trial ID | NCT07654166 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with oral fibromas on labial or buccal mucosa requiring excisional biopsy, without pregnancy, anticoagulant use, infectious diseases, immunosuppression, uncontrolled diabetes, or medications affecting healing.
✕Probably not a fit
Patients with conditions or medications that impair wound healing or increase infection risk may not benefit from the adhesive approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
In this randomized trial, adults with oral fibromas undergo excisional biopsy and are assigned to close the wound with either PeriAcryl 90 HV tissue adhesive or nylon 4-0 sutures. The primary goal is to compare wound closure performance between the adhesive and sutures in the oral cavity, including ease of use and healing outcomes. The study aims to determine if the adhesive offers a practical alternative that may reduce procedural time and avoid suture removal. 28 participants (14 per group) are planned, with assessments of healing and complications following closure.
Why it matters
Potential benefit: If successful, patients could experience faster closure, less discomfort, and no need for suture removal.
How similar studies have gone: Previous wound-closure studies outside the oral cavity have shown promise for tissue adhesives, but direct evidence in oral biopsy sites is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: -Patients clinically diagnosed with oral fibroma located on the labial mucosa (lip) or buccal mucosa (cheek). * Lesion requires excisional biopsy. * Lesion size greater than 3 mm and less than 3 cm in greatest diameter. Exclusion Criteria: * Pregnant or breastfeeding women. * Patients taking anticoagulant medications (blood thinners). * Patients with infectious diseases such as hepatitis, HIV, etc. * Patients taking immunosuppressants. * Patients with uncontrolled diabetes mellitus. * Patients taking medications that affect bleeding and wound healing.
Where it's running
-
Damascus University ,Department of Oral Medicine, Faculty of Dentistry
Damascus, Mazzh, Syria Recruiting
Study contacts
- Study coordinator: Nour J Ibrahim, DDS _ MSc student
- Email: nouribrahim649@gmail.com
- Phone: +963959800513
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Dezocine versus nalbuphine with sufentanil for pain control after oral cancer surgery with free-flap reconstruction
This will see if adding dezocine or nalbuphine to sufentanil reduces pain and complications for adults undergoing oral cancer surgery with free-flap reconstruction.
-
Comparing two surgical approaches for early mouth cancers
This study is testing whether a less invasive surgery for early mouth cancers can provide similar survival rates while being easier on patients and more affordable than the standard approach.
-
Screening for early detection of oral cancer and related disorders
This study is testing a new, easy way to check for early signs of oral cancer in high-risk people, like tobacco and heavy alcohol users, to help catch it sooner and improve survival rates.
-
Chemotherapy for advanced oral cancer patients with high cyclin D1 expression
This study is testing if a specific chemotherapy treatment can help people with advanced oral cancer who have high levels of a protein called cyclin D1 live longer and stay cancer-free after treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.